Literature DB >> 33112566

The Associations of Common Genetic Susceptibility Variants with Breast Cancer in Jordanian Arabs: A Case-Control Study.

Laith N Al-Eitan1, Doaa M Rababa'h2, Hatem A Aman2.   

Abstract

OBJECTIVE: In Jordan, breast cancer (BC) affects a substantial proportion of Jordanian women, highlighting the need for studies to be carried out regarding the genetic component of the disease. The aim of the present study was to investigate the interaction between BC risk and prognosis and polymorphisms in genes (ATM, CASP8, FGFR2, FN1, IGF1, LSP1, MAP3K, MMP7, and RHOC) that were chosen for this study previously reported as having a role in the disease.
MATERIALS AND METHODS: Blood samples were collected from 242 BC patients and 231 disease-free volunteers recruited from the Jordanian population. DNA was extracted from blood and each sample was sent to the Australian Genome Research Facility for genotyping.
RESULTS: The rs1219648 SNP of the FGFR2 gene was the only investigated variant to show any direct association with BC in Jordanian women (p-value = 0.04). However, the CASP8rs6760993 SNP was found to be significantly associated with BC (p-value = 0.04) when using the dominant model. Other gene polymorphisms showed varying levels of association between some investigated SNPs and different BC risk and prognostic factors.
CONCLUSION: Despite reports to the contrary in other populations, most of the investigated genes and their respective SNPs did not show any significant association with BC in Jordanian women. Our results underline the need for independent BC research to be carried out in the Jordanian population to decipher the genetic basis of the disease.<br />.

Entities:  

Keywords:  Genetic susceptibility; SNPs; breast cancer

Mesh:

Substances:

Year:  2020        PMID: 33112566      PMCID: PMC7798142          DOI: 10.31557/APJCP.2020.21.10.3045

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  57 in total

Review 1.  Genetic susceptibility loci for breast cancer by estrogen receptor status.

Authors:  Montserrat Garcia-Closas; Stephen Chanock
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

2.  Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.

Authors:  Laith N Al-Eitan; Reem I Jamous; Rame H Khasawneh
Journal:  Cancer Invest       Date:  2017-03-08       Impact factor: 2.176

3.  Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Authors:  Celine M Vachon; Christopher G Scott; Peter A Fasching; Per Hall; Rulla M Tamimi; Jingmei Li; Jennifer Stone; Carmel Apicella; Fabrice Odefrey; Gretchen L Gierach; Sebastian M Jud; Katharina Heusinger; Matthias W Beckmann; Marina Pollan; Pablo Fernández-Navarro; Anna Gonzalez-Neira; Javier Benitez; Carla H van Gils; Mariëtte Lokate; N Charlotte Onland-Moret; Petra H M Peeters; Judith Brown; Jean Leyland; Jajini S Varghese; Douglas F Easton; Deborah J Thompson; Robert N Luben; Ruth M L Warren; Nicholas J Wareham; Ruth J F Loos; Kay-Tee Khaw; Giske Ursin; Eunjung Lee; Simon A Gayther; Susan J Ramus; Rosalind A Eeles; Martin O Leach; Gek Kwan-Lim; Fergus J Couch; Graham G Giles; Laura Baglietto; Kavitha Krishnan; Melissa C Southey; Loic Le Marchand; Laurence N Kolonel; Christy Woolcott; Gertraud Maskarinec; Christopher A Haiman; Kate Walker; Nichola Johnson; Valeria A McCormack; Margarethe Biong; Grethe I G Alnaes; Inger Torhild Gram; Vessela N Kristensen; Anne-Lise Børresen-Dale; Sara Lindström; Susan E Hankinson; David J Hunter; Irene L Andrulis; Julia A Knight; Norman F Boyd; Jonine D Figuero; Jolanta Lissowska; Ewa Wesolowska; Beata Peplonska; Agnieszka Bukowska; Edyta Reszka; JianJun Liu; Louise Eriksson; Kamila Czene; Tina Audley; Anna H Wu; V Shane Pankratz; John L Hopper; Isabel dos-Santos-Silva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-27       Impact factor: 4.254

4.  Lifestyle related risk factors for breast cancer in Jordanian females.

Authors:  Manar F Atoum; Huda M Al-Hourani
Journal:  Saudi Med J       Date:  2004-09       Impact factor: 1.484

5.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Authors:  Anthony Renwick; Deborah Thompson; Sheila Seal; Patrick Kelly; Tasnim Chagtai; Munaza Ahmed; Bernard North; Hiran Jayatilake; Rita Barfoot; Katarina Spanova; Lesley McGuffog; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-07-09       Impact factor: 38.330

Review 6.  Insulin-like growth factor system in cancer: novel targeted therapies.

Authors:  Varsha P Brahmkhatri; Chinmayi Prasanna; Hanudatta S Atreya
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

7.  The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.

Authors:  William Tapper; Victoria Hammond; Sue Gerty; Sarah Ennis; Peter Simmonds; Andrew Collins; Diana Eccles
Journal:  Breast Cancer Res       Date:  2008-12-18       Impact factor: 6.466

8.  Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Am J Epidemiol       Date:  2009-01-06       Impact factor: 4.897

9.  Genome-wide association study identifies novel breast cancer susceptibility loci.

Authors:  Douglas F Easton; Karen A Pooley; Alison M Dunning; Paul D P Pharoah; Deborah Thompson; Dennis G Ballinger; Jeffery P Struewing; Jonathan Morrison; Helen Field; Robert Luben; Nicholas Wareham; Shahana Ahmed; Catherine S Healey; Richard Bowman; Kerstin B Meyer; Christopher A Haiman; Laurence K Kolonel; Brian E Henderson; Loic Le Marchand; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Diana Eccles; D Gareth Evans; Julian Peto; Olivia Fletcher; Nichola Johnson; Sheila Seal; Michael R Stratton; Nazneen Rahman; Georgia Chenevix-Trench; Stig E Bojesen; Børge G Nordestgaard; Christen K Axelsson; Montserrat Garcia-Closas; Louise Brinton; Stephen Chanock; Jolanta Lissowska; Beata Peplonska; Heli Nevanlinna; Rainer Fagerholm; Hannaleena Eerola; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; David J Hunter; Susan E Hankinson; David G Cox; Per Hall; Sara Wedren; Jianjun Liu; Yen-Ling Low; Natalia Bogdanova; Peter Schürmann; Thilo Dörk; Rob A E M Tollenaar; Catharina E Jacobi; Peter Devilee; Jan G M Klijn; Alice J Sigurdson; Michele M Doody; Bruce H Alexander; Jinghui Zhang; Angela Cox; Ian W Brock; Gordon MacPherson; Malcolm W R Reed; Fergus J Couch; Ellen L Goode; Janet E Olson; Hanne Meijers-Heijboer; Ans van den Ouweland; André Uitterlinden; Fernando Rivadeneira; Roger L Milne; Gloria Ribas; Anna Gonzalez-Neira; Javier Benitez; John L Hopper; Margaret McCredie; Melissa Southey; Graham G Giles; Chris Schroen; Christina Justenhoven; Hiltrud Brauch; Ute Hamann; Yon-Dschun Ko; Amanda B Spurdle; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jaana Hartikainen; Nicholas E Day; David R Cox; Bruce A J Ponder
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

10.  Correlation between Candidate Single Nucleotide Variants and Several Clinicopathological Risk Factors Related to Breast Cancer in Jordanian Women: A Genotype-Phenotype Study.

Authors:  Laith N Al-Eitan; Doaa M Rababa'h; Mansour A Alghamdi; Rame H Khasawneh
Journal:  J Cancer       Date:  2019-08-08       Impact factor: 4.207

View more
  1 in total

1.  Risk Association of TOX3 and MMP7 Gene Polymorphisms with Sporadic Breast Cancer in Mexican Women.

Authors:  Orlando Solis-Coronado; Mónica Patricia Villarreal-Vela; Hazyadee Frecia Rodríguez-Gutiérrez; Juan Francisco González-Guerrero; Ricardo M Cerda-Flores; Fernando Alcorta-Núñez; Karen Paola Camarillo-Cárdenas; Diana Cristina Pérez-Ibave; Oscar Vidal-Gutiérrez; Genaro A Ramírez-Correa; María Lourdes Garza-Rodríguez
Journal:  Curr Oncol       Date:  2022-02-11       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.